Table 4.

Kaplan Meier prognostic values of the 17 biomarker.

	LUAD		LUSC
	HR (95% CIs)	P-value/FDR	HR (95% CIs)	P-value/FDR
KRT17	1.28 (1.01–1.61)	0.037/0.0629	1.11 (0.88–1.4)	0.39/0.947
KRT14 (EBS4)	1.19 (0.94–1.5)	0.14/0.2164	1.2 (0.95–1.52)	0.13/1
KRT6A (K6C)	1.67 (1.32–2.12)	1.6e−05/0.00014	0.99 (0.78–1.25)	0.92/0.98
KRT5	1.14 (0.9–1.43)	0.28/0.366	1 (0.79–1.27)	1/1
S100A2	1.73 (1.36–2.19)	4.3e−06/7.31E−5	1.07 (0.85–1.36)	0.55/1
TUBA1C	1.1 (0.87–1.39)	0.43/0.522	1.2 (0.94–1.52)	0.14/0.793
CELSR2	0.92 (0.73–1.16)	0.47/0.533	0.79 (0.62–1)	0.049/0.833
TRIM29	1.31 (1.04–1.66)	0.022/0.0416	0.93 (0.74–1.18)	0.57/0.969
REPS1	1.38 (1.08–1.76)	0.0093/0.0226	0.9 (0.66–1.23)	0.51/1
PERP	0.67 (0.52–0.85)	0.0012/0.0051	0.85 (0.62–1.16)	0.3/0.85
NECTIN1 (PVRL1)	1.19 (0.94–1.5)	0.14/0.198	0.94 (0.74–1.2)	0.63/0.974
GPC1	1.36 (1.08–1.72)	0.0091/0.0258	0.98 (0.77–1.23)	0.83/1
MUC1	1.02 (0.81–1.29)	0.84/0.084	1.02 (0.8–1.29)	0.88/1
ELFN2	0.72 (0.56–0.92)	0.0076/0.02584	1.07 (0.78–1.47)	0.67/0.876
ARHGEF38 (FLJ20184)	0.97 (0.77–1.23)	0.83/0.882	1.16 (0.91–1.47)	0.22/0.748
ARHGAP12	0.61 (0.48–0.77)	2.3e−05/0.00013	1.17 (0.93–1.49)	0.18/0.765
QSOX1	0.76 (0.6–0.96)	0.021/0.0446	0.95 (0.75–1.2)	0.66/0.935